BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20531187)

  • 21. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
    Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
    Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
    Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
    J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric borderline ovarian tumors: a retrospective analysis.
    Song T; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    J Pediatr Surg; 2010 Oct; 45(10):1955-60. PubMed ID: 20920712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.
    Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N
    J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface epithelial tumours of the ovary.
    Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
    Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
    Kadar N; Krumerman M
    Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
    Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
    Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian tumours: a study of 282 cases.
    Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
    J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Borderline ovarian tumors and global radiation in relation with climate change impact].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):813-9. PubMed ID: 22046792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI appearances of borderline ovarian tumours.
    Bent CL; Sahdev A; Rockall AG; Singh N; Sohaib SA; Reznek RH
    Clin Radiol; 2009 Apr; 64(4):430-8. PubMed ID: 19264189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases.
    Stewart CJ; Brennan BA; Hammond IG; Leung YC; McCartney AJ
    Int J Gynecol Pathol; 2006 Jul; 25(3):216-22. PubMed ID: 16810056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of topoisomerase III alpha in epithelial ovarian tumors of different types and relation between the expression of topoisomerase III alpha and the clinical pathology of tumor].
    Zhang WY; Pan Y; Zhu LR; Zhang JZ; Zhang M; Feng K; Zhou L; Yu L; Zhang XM; Ng SW
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2988-91. PubMed ID: 16324386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.